Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials. While stem cell therapies can be effective, they are also associated with some risks of both tumor growth and immune rejection. Also, the cells themselves are very fragile, requiring careful storage and a multi-step process of typing and characterization before they can be used.
Ke Cheng, associate professor of molecular biomedical sciences at NC State, associate professor in the joint biomedical engineering program at NC State and UNC, and adjunct associate professor at the UNC Eshelman School of Pharmacy, led a team in developing the synthetic version of a cardiac stem cell that could be used in off-the-shelf applications.
Cheng and his colleagues fabricated a cell-mimicking microparticle (CMMP) from poly (lactic-co-glycolic acid) or PLGA, a biodegradable and biocompatible polymer. The researchers then harvested growth factor proteins from cultured human cardiac stem cells and added them to the PLGA. Finally, they coated the particle with cardiac stem cell membrane.
“We took the cargo and the shell of the stem cell and packaged it into a biodegradable particle,” Cheng says.
When tested in vitro, both the CMMP and cardiac stem cell promoted the growth of cardiac muscle cells. They also tested the CMMP in a mouse model with myocardial infarction, and found that its ability to bind to cardiac tissue and promote growth after a heart attack was comparable to that of cardiac stem cells. Due to its structure, CMMP cannot replicate – reducing the risk of tumor formation.
“The synthetic cells operate much the same way a deactivated vaccine works,” Cheng says. “Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.”
The synthetic stem cells are much more durable than human stem cells, and can tolerate harsh freezing and thawing. They also don’t have to be derived from the patient’s own cells. And the manufacturing process can be used with any type of stem cell.
“We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they’re needed, without costly delays,” Cheng says.
Receive an email update when we add a new STEM CELLS article.
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Stem Cell Research Unlocks a New Discovery about Controlling Geneson April 9, 2021 at 8:57 am
The DNA in our genes contains the instructions needed to manufacture all of the proteins in our cells. These proteins, in turn, do the work that keeps our bodies functioning. Therefore, knowing how ...
- A new international consortium to promote stem cell-based therapy for Huntington's diseaseon April 9, 2021 at 8:47 am
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's ...
- Stem Cells Market Size 2021: Market Share, Top Companies report covers are Osiris Therapeutics,NuVasive,Chiesi Pharmaceuticalon April 8, 2021 at 11:01 pm
Stem Cells Market “ Size, Status and Market Insights 2021, ,Stem Cells Market By Type (Allogeneic,Autologous,,), ...
- Study: Age-related changes in brain stem cells are more pronounced in male animalson April 8, 2021 at 10:11 pm
Ageing and age-related brain disease do not affect women and men in the same way. The adult brain constantly generates new brain cells called neurons from stem cells, a process called neurogenesis.
- Neuromuscular fatigue and recovery after strenuous exercise depends on skeletal muscle size and stem cell characteristicson April 8, 2021 at 10:08 am
Moreover, we established that a lower myoblast:fibroblast ratio in isolated primary human muscle stem cells correlated with improved recovery from both repeated maximal sprints and an in vitro ...
- Scientists identify new differences between the sexes in age-related changes to brain stem cellson April 8, 2021 at 8:01 am
The adult brain constantly generates new brain cells called neurons from stem cells, a process called neurogenesis. This process is important for learning and cognitive function which declines as ...
- Global stem cell market size to register 7.54% CAGR through 2028on April 8, 2021 at 3:00 am
The latest business intelligence report on ‘global stem cell market’ provides a detailed picture of the factors that will dictate the industry’s growth over the forecast period 2021-2028. Moreover, to ...
- Long-term effects of human induced pluripotent stem cell-derived retinal cell transplantation in Pde6b knockout ratson April 7, 2021 at 10:06 pm
cells; however, the long-term effect of implanting both human induced pluripotent stem cell (hiPSC)-derived RPE and photoreceptor for retinal regeneration has not yet been investigated. In this study, ...
- Light shed on the coordination of neural stem cell activationon April 7, 2021 at 9:00 pm
Scientists at the Institut Pasteur, CNRS, and Tel Aviv University working in collaboration with the École Polytechnique and INRAE have successfully performed 3D visualization and spatial and temporal ...
via Bing News